Loading
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (18 ops.)
Latest filing published 19 Mar 2026 for CytomX Therapeutics, Inc., €119k.
Filing timeline
BuySaleYu-Waye Chu
Insider track record
Disclosed buys
0
Disclosed sells
18
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Yu-Waye Chu: trading record in brief
Yu-Waye Chu has filed trades across 2 companies (mainly through SEC (Form 4)), most often in Fate Therapeutics Inc and CytomX Therapeutics, Inc. Between 16 April 2021 and 17 March 2026, the trades on record add up to 25 filings.
No open-market purchase appears, only 18 sales worth €1.0M. The rest of the record consists of 6 share grants and 1 option exercise. 2026 to date brings no purchases and 1 sale.
The newest entry dates from 19 March 2026: an open-market sale of €119k, in CytomX Therapeutics, Inc. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. The legal deadline for a Form 4 is two business days after the transaction. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to Yu-Waye Chu
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations12 total
21,279 shares@ US$6.42398.2% of flowCommon StockSEC:0001610717-26-000125:0
75,000 shares0Common StockSEC:0001610717-26-000042:0
4,025 shares@ US$0.599100.0% of flowCommon StockSEC:0001610717-25-000084:0
56,000 shares0Common StockSEC:0001610717-25-000018:0
26,250 shares0Common StockSEC:0001610717-24-000031:0
215 shares@ US$6.520.2% of flowCommon StockSEC:0001209191-23-024820:0
7,825 shares@ US$5.245.5% of flowCommon StockSEC:0001209191-23-002974:0
4,062 shares@ US$35.3730.8% of flowCommon StockSEC:0001209191-22-025159:0
33,302 shares0Common StockSEC:0000899243-22-003448:0
3,547 shares@ US$48.4435.1% of flowCommon StockSEC:0001209191-22-003166:0
7,500 shares@ US$16.3225.1% of flowCommon StockSEC:0001209191-21-069313:0
60,958 shares0Common StockSEC:0001209191-21-066156:0
12 of 12 declarations
